Concepedia

Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study)

Victor F. Tapson, Zhi‐Cheng Jing, Kai‐Feng Xu, Lei Pan, Jeremy Feldman, David G. Kiely, Eugene Kotlyar, C. Shane McSwain, Kevin Laliberte, Carl Arneson,

CHEST Journal · 2013 · 292 citations · 14 references

DOI

Concepts

References

14

Bosentan Therapy for Pulmonary Arterial Hypertension

Lewis J. Rubin, David B. Badesch, Robyn J. Barst et al. · New England Journal of Medicine · 2002 · 2.7K citations · Full text

, , +17

ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension

Vallerie V. McLaughlin, Stephen L. Archer, David B. Badesch et al. · Journal of the American College of Cardiology · 2009 · 2.4K citations

, , +16

Continuous Subcutaneous Infusion of Treprostinil, a Prostacyclin Analogue, in Patients with Pulmonary Arterial Hypertension: A Double-blind, Randomized, Placebo-controlled Trial

Gérald Simonneau, Robyn J. Barst, Nazzareno Galiè et al. · American Journal of Respiratory and Critical Care Medicine · 2002 · 1.4K citations

, , +11

Ambrisentan for the Treatment of Pulmonary Arterial Hypertension

Nazzareno Galiè, Horst Olschewski, Ronald J. Oudiz et al. · Circulation · 2008 · 1.1K citations

, , +16

Randomized Study of Adding Inhaled Iloprost to Existing Bosentan in Pulmonary Arterial Hypertension

Vallerie V. McLaughlin, Ronald J. Oudiz, Adaani Frost et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 625 citations

, , +14